[1]
2025. EARLY DETERMINATION RISKS OF ATHEROSCLEROSIS IN THE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE. International journal of medical sciences. 5, 12 (Dec. 2025), 1019–1023. DOI:https://doi.org/10.55640/.